What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
David M. Goldenberg mainly focuses on Antibody, Monoclonal antibody, Pathology, Radioimmunotherapy and Cancer. His Antibody research includes themes of Molecular biology, In vivo and Antigen. His research in Monoclonal antibody focuses on subjects like Pharmacology, which are connected to SN-38, Sacituzumab govitecan and Antibody-drug conjugate.
He has included themes like Pharmacokinetics, Carcinoembryonic antigen, Head and neck cancer and Metastasis in his Pathology study. His Radioimmunotherapy study incorporates themes from Gastroenterology, Nuclear medicine, Toxicity, Radiation therapy and Bone marrow. His Cancer research includes elements of Cancer research and Oncology.
His most cited work include:
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning (674 citations)
- Immunotherapy of B-cell malignancies using anti-CD22 antibodies (428 citations)
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy (303 citations)
What are the main themes of his work throughout his whole career to date?
Antibody, Internal medicine, Monoclonal antibody, Pathology and Radioimmunotherapy are his primary areas of study. His biological study spans a wide range of topics, including Molecular biology, Cancer research, Antigen and Carcinoembryonic antigen. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Oncology.
His studies deal with areas such as In vivo, Biodistribution and Pharmacology as well as Monoclonal antibody. His study of Carcinoma is a part of Pathology. David M. Goldenberg interconnects Nuclear medicine, Radiation therapy, Toxicity and Bone marrow in the investigation of issues within Radioimmunotherapy.
He most often published in these fields:
- Antibody (24.66%)
- Internal medicine (19.08%)
- Monoclonal antibody (18.39%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (19.08%)
- Cancer (15.98%)
- Surgery (11.50%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cancer, Surgery, Oncology and Sacituzumab govitecan. His studies in Internal medicine integrate themes in fields like Gastroenterology and Immunology. His Cancer study integrates concerns from other disciplines, such as Cancer research and Epidemiology, Pathology.
His study focuses on the intersection of Cancer research and fields such as Antibody with connections in the field of Molecular biology. His Surgery research incorporates elements of Thyroid and Thyroid cancer. Many of his studies on Oncology apply to Radioimmunotherapy as well.
Between 2013 and 2021, his most popular works were:
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. (157 citations)
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. (151 citations)
- Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) (133 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His main research concerns Internal medicine, Cancer, Sacituzumab govitecan, Pharmacology and Antibody-drug conjugate. His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine. The concepts of his Cancer study are interwoven with issues in Cancer research, Epidemiology and Human papillomavirus.
His Cancer research study also includes
- Immunology which is related to area like In vivo,
- Antigen which connect with Pathology and Immunohistochemistry. His Pathology study combines topics from a wide range of disciplines, such as Molecular imaging, Prostate cancer and Monoclonal antibody. David M. Goldenberg combines subjects such as Immune system and Immunotherapy with his study of Antibody.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
